Description
Retatrutide (LY3437943) is a potent triple agonist peptide targeting the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). This multi-pathway mechanism is designed to optimize metabolic regulation, weight management research, and glycemic control through synergistic hormonal signaling.




Reviews
There are no reviews yet.